Charles Pugar, DO
Vascular Surgery · Columbus, OHNPI 1932350626
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (58.0%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Medtronic at 43.9% of the total. 2025 is the largest year on record at $8,493, 3.9 times the $2,161 reported in 2019.
Across 195 payments — averaging $97.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$8K
- W. L. Gore & Associates, Inc.$4K
- Silk Road Medical, Inc.$1K
- Endologix LLC$1K
- Bard Peripheral Vascular, Inc.$1K
- Cook Medical LLC$506
- plus $3K from 24 others
What the payments were for
- Speaking & faculty fees$1,80010%
- Travel & lodging$6,16333%
- Food & beverage$10,97458%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 75 | $8,310 |
| W. L. Gore & Associates, Inc. | 29 | $4,064 |
| Silk Road Medical, Inc. | 10 | $1,281 |
| Endologix LLC | 8 | $1,115 |
| Bard Peripheral Vascular, Inc. | 5 | $1,071 |
| Cook Medical LLC | 12 | $506 |
| Organogenesis Inc. | 5 | $466 |
| Smith+Nephew | 10 | $400 |
| Inari Medical, Inc. | 3 | $220 |
| Kerecis Limited | 2 | $183 |
| Tactile Systems Technology Inc | 3 | $172 |
| Reflow Medical Inc | 1 | $157 |
| Contego Medical, Inc | 2 | $153 |
| Shockwave Medical, Inc | 1 | $114 |
| Boston Scientific | 6 | $110 |
| Cardiovascular Systems Inc. | 3 | $92 |
| Philips North America LLC | 4 | $85 |
| Angiodynamics, Inc. | 2 | $78 |
| Abbott | 3 | $74 |
| Davol Inc. | 1 | $62 |
| Stryker | 1 | $51 |
| BD | 1 | $32 |
| Thrombolex, Inc. | 1 | $27 |
| Avinger Inc. | 1 | $24 |
| Cagent Vascular Inc | 1 | $19 |
| Lundbeck LLC | 1 | $18 |
| Cardinal Health 200 LLC | 1 | $15 |
| Avenu Medical Inc. | 1 | $13 |
| KCI USA, Inc. | 1 | $13 |
| Lemaitre Vascular, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENDURANT IIS$1,699
- NA$1,441
- IN.PACT Admiral$1,266
- ENROUTE Transcarotid Neuroprotection System$1,264
- GORE TAG Thoracic Endoprosthesis$1,239
- Product in Development$999
- ENROUTE Transcarotid Stent System$856
- ENHANCE Transcarotid Peripheral Access Kit$856
- ENROUTE 0.014 Guidewire$856
- GORE TAG Thoracic Branch Endoprosthesis$385
- ENROUTE Transcarotid Stent$284
- Alto Abdominal Stent Graft System$284
- Torus Stent Graft System$230
- ENDOCROSS Device$230
- Kerecis Omega3 Wound$173
- Endurant$170
- FLOWTRIEVER CATHETER, S$163
- CT THROMBECTOMY SYSTEM KIT$163
- Zenith$157
- AFX2 Bifurcated Endograft System$156
How this compares
$18,936 in reported general payments places this provider in the 85th percentile of 213 vascular surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 44 | $36,432 |
| EliquisApixaban | 20 | $16,631 |
| ClopidogrelClopidogrel Bisulfate | 258 | $1,440 |
| Atorvastatin Calcium | 67 | $469 |
| Cilostazol | 43 | $385 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Columbus
- Simon FraserColumbus$25K
- Kapil GopalColumbus$23K
- Andrew YangColumbus$13K
- David EpsteinColumbus$11K
- Patrick MuckCincinnati$650K
- Sean LydenCleveland$561K
- Brian KuhnCincinnati$184K
- Vikram RaoWilloughby$137K
- Federico ParodiCleveland$78K
- Francis CaputoCleveland$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.